Eric Bell

Eric Bell is currently the Director of Translational Science at Rectify Pharma, with previous roles as an Associate Director in Biology at FORMA Therapeutics and Program Lead at Amathus Therapeutics. Before transitioning into industry roles, Eric conducted research as a Postdoctoral Fellow and Research Scientist at Massachusetts Institute of Technology and as a Graduate Student at Northwestern University. Eric has a PhD in Cell and Molecular Biology from Northwestern University and a Bachelor of Science in Biology from the University of Delaware.